Johann von Felden

33PUBLICATIONS
134CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersMedical biochemistry - carbohydratesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Aug 06, 2026
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCC.

|Jun 23, 2026
Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

|Jun 03, 2026
TGF-β1 and TGF-β2 family members differentially modulate tumor initiation and invasiveness of primary liver cancer in a MMP14-dependent manner.

|Aug 28, 2025
A dual compartment peripheral blood signature of soluble and membrane-bound immune checkpoints predicts outcome in lymphoma patients.

Joao Gorgulho, Timo Trenkner, Eva Kinkel

|Mar 31, 2025
Endoscopic findings of Bouveret syndrome.

Johann von Felden, Julian Schulze Zur Wiesch, Tarik Ghadban

|Oct 05, 2024
Editorial: Predictive Factors and Survival Outcome of Conversion Therapy for Unresectable Hepatocellular Carcinoma Patients Receiving Atezolizumab and Bevacizumab: Comparative Analysis of Conversion, Partial Response and Complete Response Patients.

Joao Gorgulho, Johann von Felden

Pageof 6

Frequent Collaborators

6 joint publications

Samuel Huber

6 joint publications

Augusto Villanueva

5 joint publications

Ismail Labgaa

5 joint publications

Bernhard Scheiner